Company / Cash per Share
Cogent Biosciences, Inc. Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.42
FY2025
5-year range
$0.67 / $5.67
FY2021-FY2025
Trend
+156.1%
vs FY2024
Sector context
#89 of 207
Health Care
What the data says
At $2.42, Cogent Biosciences, Inc.'s cash per share ranks #89 of 207 in the Health Care sector. Cash per Share has fluctuated over the past 9 years, ranging from $0.67 in FY2023 to $21.86 in FY2020.
Based on SEC 10-K filings.
2.42 in FY2025 with a 5-year CAGR of -35.6%.
Improved from $0.67 to $2.42 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- -35.6%
- 10-Year CAGR
- -
Sector benchmark
#89 of 207 in Health CareTop 43% of 207This company $2.42 Sector average $67.39
▼
-96.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 156.1% year-over-year.
- Ranks #89 out of 207 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.42 | +156.1% |
| FY2024 | $0.95 | +41.5% |
| FY2023 | $0.67 | -71.9% |
| FY2022 | $2.38 | -58.0% |
| FY2021 | $5.67 | -74.0% |
| FY2020 | $21.86 | +345.0% |
| FY2019 | $4.91 | +119.6% |
| FY2018 | $2.24 | -19.4% |
| FY2017 | $2.77 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026